Satipharm
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10 Queen Street Pl, London, Greater Lond...Phone Number
(604) 687-3338Website
www.satipharm.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Satipharm
Satipharm is a health and wellness company which is specialised in the development and manufacture of cannabinoid-based products from the cannabis plant. Our mission is to deliver the highest quality products that are designed specifically with the needs of our customers in mind.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Satipharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Satipharm, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Satipharm has new funding data
Earning: See what the market has to say on Satipharm recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Satipharm
Check if Satipharm has recently received funding, and reach out quickly before it becomes old news!
Click to see if Satipharm had a recent Job posting/layoffs
Check out if Satipharm is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Satipharm launches new products
Recommended Actions
Find VP level buyers at Satipharm
Find 2 more new buyers
Compare Similar Companies to Satipharm
Compare insights from companies similar to Satipharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Satipharm
<$5M
1-10
Private
-
2015
N/A
Company Profile Activity
Activity Insights
Satipharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Satipharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Satipharm.
Satipharm Tech Stack
A closer look at the technologies used by Satipharm
Satipharm News & Media
Harvest One Announces Agreement to Sell Satipharm for Approximately $4 Million and Imminent Completion of Its Strategic Review Process
Satipharm sale reinforces Harvest One's strategic realignment and transition to become a cannabis-focused Consumer Packaged Goods ("CPG") companyHarvest One has the opportunity to continue to represent Satipharm-branded products in North AmericaVancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF) ("Harvest One" or the "Company"), a uniquely positioned, cannabis-infused CPG leader, announced today that it has entered into a definHarvest One Subsidiary Satipharm Granted US Patent Covering Gelpell(TM) Technology
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2020) - Harvest One Cannabis Inc. (TSXV: HVT) (OTCQX: HRVOF) ("Harvest One" or the "Company") announced today that the United States Patent and Trademark Office has granted its wholly-owned subsidiary Satipharm Ltd. ("Satipharm") US Pat No. 10,555,906 covering Satipharm's proprietary Gelpell™ technology.This issued patent, titled "Oral solid cannabinoid formulations, methods for producing and use thereof", protects Satipharm's licencedSatipharm initiates clinical research into the use of CBD for relief from menopause symptoms
Health and wellness company Satipharm Ltd. ("Satipharm" or the "Company") has initiated clinical research into the use of CBD for relief from menopause symptoms. Following the successful completion of its Phase II clinical trial demonstrating that Satipharm CBD capsules reduced seizures in children with treatment-resistant epilepsy by an average 73%, the company is now turning its attention to perimenopause and menopause.Harvest One Launches New Satipharm CBD Oil
Available Across Europe for Online Sales VANCOUVER, Aug. 19, 2019 /PRNewswire/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSXV: HVT; OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm Ltd. ("Satipharm") today announced it has expanded its product portfolio...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Satipharm
Sign Up For FreeTo access detailed company insights
Satipharm is a health and wellness company which is specialised in the development and manufacture of cannabinoid-based products from the cannabis plant. Our mission is to deliver the highest quality products that are designed specifically with the needs of our customers in mind.... Read More
